A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice

Immunology

Volumn 100, Issue 1, 2000, Pages 99-109

  Ono, S ^a   Shao, D Z ^a   Yamada, S ^a   Yang, Y ^a   Yamashita, M ^a   Hamaoka, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HYPERGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SPLEEN CELL; SPLENOMEGALY; X CHROMOSOME LINKAGE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; FEMALE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE TRANSFUSION; MALE; MICE; MICE, INBRED NZB; MICE, INBRED STRAINS; SPLEEN;

EID: 0034092884     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00005.x     Document Type: Article

References (43)

1. 1. THEOFILOPOULOS A.N. & DIXON F.J. (1985) Murine models of systemic lupus erythematosus. Adv Immunol 37, 269.
2. 2. STEWARD M.W. & HAY F.C. (1976) Changes in immunoglobulin class and subclass of anti-DNA antibody with increasing age in NZB/W F1 hybrid mice. Clin Exp Immunol 26, 363.
3. 3. PAPOIAN R., PILLARISETTY R. & TALAL N. (1977) Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology 32, 75.
4. 4. IZUI S., MCCONAHEY P.J. & DIXON F.J. (1978) Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol 121, 2213.
5. 5. PRUD'HOMME G.J., BALDERAS R.S., DIXON F.J. & THEOFILOPOULOS A.N. (1983) B cell dependence on and response to accessory signals in murine lupus strains. J Exp Med 157, 1815.
6. 6. MIHARA M., OHSUGI Y., SAITO K. et al. (1988) Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals. J Immunol 141, 85.
7. id gene or generalized polyclonal B cell activation. J Immunol 128, 2220.
8. 8. STEINBERG B.J., SMATHERS P.A., FREDERIKSEN K. & STEINBERG A.D. (1982) Ability of the xid gene into prevent autoimmunity in (NZB × NZW) F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J Clin Invest 70, 587.
9. 9. AKIZUKI M., REEVES J.P. & STEINBERG A.D. (1978) Expression of autoimmunity by NZB/NZW marrow. Clin Immunol Immunopathol 10, 247.
10. 10. REININGER L., RADASZKIEWICZ T., KOSCO M., MELCHERS F. & ROLINK A.G. (1992) Development of autoimmune disease in SCID mice populated with long-term 'in vitro' proliferating (NZB × NZW) F1 pre-B cells. J Exp Med 176, 1343.
11. 11. REININGER L., WINKLER T.H., KALBERER C.P., JOURDAN M., MELCHERS F. & ROLINK A.G. (1996) Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB × NZW) F1 mice. J Exp Med 184, 853.
12. 12. MOREL L., TIAN X.H., CROKER B.P. & WAKELAND E.K. (1999) Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11, 131.
13. 13. HAMAOKA T., MURAKAMI S., DOBASHI K. et al. (1988) I-A-restricted B-B cell interaction and its relation to autoimmunity. In: B Cell Development (edsO. WITTE M. Howard & N. KLINMAN), p. 215. Alan R. Liss, Inc., New York.
14. 14. CEREDIG R., LOWENTHAL J.W., NABHOLZ M. & MACDONALD H.R. (1985) Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314, 98.
15. 15. SARMIENTO M., GLASEBROOK A.L. & FITCH F.W. (1980) IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt-2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 125, 2665.
16. 16. HAYASHI S., ONO S., MIYAKE K., TSUKADA S., TAKATSU K. & HAMAOKA T. (1986) Evidence for existence of two distinct TNP Ficoll-responsive B cell subpopulations preferentially reactive either to a T cell-replacing factor (B151-TRF) or to a signal from accessory cells. J Immunol 136, 2069.
17. 17. OI V.T., JONES P.P., GOLDING J.W., HERZENBERG L.A. & HERZENBERG L.A. (1978) Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol 81, 115.
18. 18. YOSHIOKA T., SATO S., FUJIWARA H. & HAMAOKA T. (1986) The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo. Jpn J Cancer Res 77, 825.
19. 19. SHAO D.Z., YAMADA S., HIRAYAMA F., HIRANO H., ONO S. & HAMAOKA T. (1995) Modulation of B-cell abnormalities in lupus-prone (NZB × NZW) F1 mice by normal bone marrow-derived B-lineage cells. Immunology 85, 16.
20. 20. ONO S., TAKAHAMA Y. & HAMAOKA T. (1987) Ia-restricted B B-cell interaction. I. The MHC haplotype of bone marrow cells present during B cell ontogeny dictates the self-recognition specificity of B cells in the polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. J Immunol 139, 3213.
21. 21. SCHER I. (1982) The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol 33, 1.
22. 22. TAKEDA K. & DENNERT G. (1993) The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 177, 155.
23. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol 156, 4035.
24. 24. JACOB C.O., VAN DER MEIDE P.M. & MCDEVITT H.O. (1987) In vivo treatment of (NZB × NZW) F1 lupus-like nephritis with monoclonal antibody to γ interferon. J Exp Med 166, 798.
25. 25. NAGATA S. & GOLSTEIN P. (1995) The Fas death factor. Science 267, 1449.
26. 26. SUDA T., TAKAHASHI T., GOLSTEIN P. & NAGATA S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169.
27. 27. SOBEL E.S., KAKKANAIAH V.N., COHEN P.L. & EISENBERG R.A. (1993) Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int Immunol 5, 1275.
28. 28. ETTINGER R., WANG J.K.M., BOSSU P., SIDMAN C.L., ABBAS A.K. & MARSHAK-ROTHSTEIN A. (1994) Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect. J Immunol 152, 1557.
29. 29. HAHNE M., RENNO T., SCHROETER M. et al. (1996) Activated B cells express functional Fas ligand. Eur J Immunol 26, 721.
30. 30. MAEDA A., KUROSAKI M., ONO M., TAKAI T. & KUROSAKI T. (1998) Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med 187, 1355.
31. 31. SOBEL E.S., KAKKANAIAH V.N., SCHIFFENBAUER J., REAP E.A., COHEN P.L. & EISENBERG R.A. (1998) Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras. J Immunol 160, 1497.
32. 32. CHAN O.T., HANNUM L.G., HABERMAN A.M., MADAIO M.P. & SHLOMCHIK M.J. (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189, 1639.
33. 33. EYNON E.E. & PARKER D.C. (1992) Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 175, 131.
34. 34. WOFSY D. & SEAMAN W.E. (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161, 378.
35. 35. MERINO R., IWAMOTO M., FOSSATI L. & IZUI S. (1993) Polyclonal B cell activataion arises from different mechanisms in lupus-prone (NZB × NZW) F1 and MRL/Mpj-lpr/lpr mice. J Immunol 151, 6509.
36. 36. HUANG F.P., FENG G.J., LINDOP G., STOTT D.I. & LIEW F.Y. (1996) The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med 183, 1447.
37. 37. NAKAJIMA A., HIROSE S., YAGITA H. & OKUMURA K. (1997) Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol 158, 1466.
38. 38. MARUO S., OH-HORA M., AHN H.J. et al. (1997) B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions. J Immunol 158, 120.
39. 39. WIJESURIYA R., MARUO S., ZOU J.P. et al. (1998) B cell-mediated down-regulation of IFN-γ and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state. Int Immunol 10, 1057.
40. 40. CYSTER J.G., HARTLEY S.B. & GOODNOW C.C. (1994) Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371, 389.
41. 41. ACHA-ORBEA H., STEINMAN L. & MCDEVITT H.O. (1989) T cell receptors in murine autoimmune diseases. Annu Rev Immunol 7, 371.
42. 42. FINCK B.K., LINSLEY P.S. & WOFSY D. (1994) Treatment of murine lupus with CTLA4Ig. Science 265, 1225.
43. 43. ISHIDA H., MACHAMUEL T., SAKAGUCHI S., ANDRADE S., MENON S. & HOWARD M. (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179, 305.